Zhengye Biotechnology Holding Cash Flow Statement (2023-2025) | ZYBT

Cash Flow Statement Dec2023 Dec2024 Jun2025
Operating Activities
Deferred Taxes 0.00B0.14B
Asset Writedowns and Impairment -0.00B0.00B
Change in Working Capital 0.00B-0.06B
Change in Receivables 0.00B0.00B
Other Working Capital Changes 0.00B0.00B
Financing Activities
Other financing activities 0.00B0.00B
Debt Issuance and Repayment
Non-Current Debt 2,000.00B
Net Debt Issuances and Repayments 2,000.00B
Additional items
Beginning Cash Balance 0.00B0.00B0.01B